Table 3 Subgroup analysis of the association between PLR and OS, CSS, RFS, PFS.

From: The serum platelet-to-lymphocyte ratio as a predictor of outcomes in bladder cancer patients: an updated meta-analysis

Survival analysis

No. of studies

HR (95% CI)

p

I2 (%)

P-value for heterogeneity

Analysis model

Meta Regression P

OS

 Total

13

1.51 (1.23, 1.85)

 < 0.001

84.5

 < 0.001

Random

 

Ethnicity

      

0.819

 Asian

6

1.45 (0.98,2.16)

0.063

76.2

0.001

Random

 

 Caucasian

7

1.54 (1.19,1.98)

0.001

86.4

 < 0.001

Random

 

Publication year

      

0.019

 Before 2020

8

1.21 (1.00,1.47)

0.050

78.8

 < 0.001

Random

 

 After 2020

5

2.14 (1.67,2.76)

 < 0.001

13.1

0.330

Random

 

Sample size

      

0.202

  < 200

7

1.97 (1.22,3.17)

0.006

87.8

 < 0.001

Random

 

  ≥ 200

6

1.26 (0.98,1.62)

0.073

68.1

0.008

Random

 

Cut-off value

      

0.941

  < 150

5

1.73 (1.06,2.83)

0.030

77.4

0.001

Random

 

  ≥ 150

8

1.44 (1.13,1.82)

0.003

86.4

 < 0.001

Random

 

Treatment

      

0.424

 TURBT

4

1.30 (0.67,2.53)

0.438

77.0

0.005

Random

 

 RC

9

1.61 (1.25,2.06)

 < 0.001

87.9

 < 0.001

Random

 

CSS

 Total

6

1.14 (0.96,1.35)

0.138

56.2

0.044

Random

 

Ethnicity

      

0.312

 Asian

3

1.42 (0.98,2.07)

0.063

0

0.459

Random

 

 Caucasian

3

1.08 (0.91,1.28)

0.371

68.9

0.040

Random

 

Sample size

      

0.244

  < 200

3

1.23 (0.73,2.09)

0.440

50.2

0.134

Random

 

  ≥ 200

3

1.21 (1.05,1.39)

0.007

0

0.964

Random

 

Cut-off value

      

0.870

  < 150

2

1.20 (0.78,1.85)

0.413

0

0.775

Random

 

  ≥ 150

4

1.14 (0.93,1.40)

0.197

71.9

0.014

Random

 

Treatment

      

0.733

 TURBT

3

1.22 (0.80,1.86)

0.358

0

0.925

Random

 

 RC

3

1.14 (0.92,1.41)

0.220

80.8

0.005

Random

 

RFS

 Total

9

1.68 (1.26,2.24)

 < 0.001

68.6

0.001

Random

 

Ethnicity

      

0.080

 Asian

5

2.00 (1.40,2.85)

 < 0.001

55.4

0.062

Random

 

 Caucasian

4

1.26(0.97,1.64)

0.080

22.3

0.277

Random

 

Publication year

      

0.935

 Before 2020

2

1.72 (0.79,3.77)

0.175

83.7

0.013

Random

 

 After 2020

7

1.70 (1.22,2.38)

0.002

54.4

0.040

Random

 

Sample size

      

0.138

  < 200

5

1.64 (1.09,2.49)

0.019

68.2

0.014

Random

 

  ≥ 200

4

1.76 (1.07,2.88)

0.026

65.5

0.034

Random

 

Cut-off value

      

0.075

  < 150

6

2.02 (1.48,2.77)

 < 0.001

46.4

0.097

Random

 

  ≥ 150

3

1.21 (1.08,1.36)

0.002

0

0.779

Random

 

Treatment

      

0.576

 TURBT

8

1.81 (1.32,2.47)

 < 0.001

53.4

0.036

Random

 

PFS

 Total

6

1.61 (1.00,2.59)

0.052

58.3

0.035

Random

 

Ethnicity

      

0.446

 Asian

3

1.81 (0.79,4.11)

0.159

74.5

0.020

Random

 

 Caucasian

3

1.44 (0.71,2.92)

0.306

51.8

0.126

Random

 

Sample size

      

0.387

  < 200

4

1.20(0.71,2.03)

0.501

45.2

0.140

Random

 

  ≥ 200

2

2.62(1.61,4.27)

 < 0.001

2.1

0.312

Random

 

Cut-off value

      

0.539

  < 150

5

1.81 (1.12,2.93)

0.016

55.6

0.061

Random

 

Treatment

      

0.282

 TURBT

5

1.90 (1.21,2.99)

0.006

40.9

0.149

Random

 
  1. NA not available, HR hazard ratios, OS overall survival, CSS cancer-specific survival, RFS recurrence-free survival, PFS progression-free survival.